TY  - JOUR
AU  - Ceulemans, Michael
AU  - Lupattelli, Angela
AU  - Nordeng, Hedvig
AU  - Odalović, Marina
AU  - Twigg, Michael J.
AU  - Foulon, Veerle
PY  - 2019
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3348
AB  - Background: During pregnancy, women might weigh the benefits of treatment against potential risks to the unborn child. However, non-adherence to necessary treatment can adversely affect both mother and child. To optimize pregnant women's beliefs and medication adherence, community pharmacists are ideally positioned to play an important role in primary care. Objective: This narrative review aimed to summarize the evidence on 1) pregnant women's beliefs, 2) medication adherence in pregnancy and 3) community pharmacists' counselling during pregnancy. Methods: Three search strategies were used in Medline and Embase to find original studies evaluating women's beliefs, medication adherence and community pharmacists' counselling during pregnancy. All original descriptive and analytic epidemiological studies performed in Europe, North America and Australia, written in English and published from 2000 onwards were included. Results: We included 14 studies reporting on women's beliefs, 11 studies on medication adherence and 9 on community pharmacists' counselling during pregnancy. Women are more reluctant to use medicines during pregnancy and tend to overestimate the teratogenic risk of medicines. The risk perception varies with the type of medicine, level of health literacy, education level and occupation. Furthermore, low medication adherence during pregnancy is common. Finally, limited evidence showed that the current community pharmacists' counselling is insufficient. Barriers hindering pharmacists are insufficient knowledge and limited access to reliable information. Conclusion: Concerns about medication use and non-adherence are widespread among pregnant women. Community pharmacists' counselling during pregnancy is insufficient. Further education, training and research are required to support community pharmacists in fulfilling all the opportunities they have when counselling pregnant women.
PB  - Bentham Science Publ Ltd, Sharjah
T2  - Current Pharmaceutical Design
T1  - Women's Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists
VL  - 25
IS  - 5
SP  - 469
EP  - 482
DO  - 10.2174/1381612825666190321110420
ER  - 

@article{
author = "Ceulemans, Michael and Lupattelli, Angela and Nordeng, Hedvig and Odalović, Marina and Twigg, Michael J. and Foulon, Veerle",
year = "2019",
abstract = "Background: During pregnancy, women might weigh the benefits of treatment against potential risks to the unborn child. However, non-adherence to necessary treatment can adversely affect both mother and child. To optimize pregnant women's beliefs and medication adherence, community pharmacists are ideally positioned to play an important role in primary care. Objective: This narrative review aimed to summarize the evidence on 1) pregnant women's beliefs, 2) medication adherence in pregnancy and 3) community pharmacists' counselling during pregnancy. Methods: Three search strategies were used in Medline and Embase to find original studies evaluating women's beliefs, medication adherence and community pharmacists' counselling during pregnancy. All original descriptive and analytic epidemiological studies performed in Europe, North America and Australia, written in English and published from 2000 onwards were included. Results: We included 14 studies reporting on women's beliefs, 11 studies on medication adherence and 9 on community pharmacists' counselling during pregnancy. Women are more reluctant to use medicines during pregnancy and tend to overestimate the teratogenic risk of medicines. The risk perception varies with the type of medicine, level of health literacy, education level and occupation. Furthermore, low medication adherence during pregnancy is common. Finally, limited evidence showed that the current community pharmacists' counselling is insufficient. Barriers hindering pharmacists are insufficient knowledge and limited access to reliable information. Conclusion: Concerns about medication use and non-adherence are widespread among pregnant women. Community pharmacists' counselling during pregnancy is insufficient. Further education, training and research are required to support community pharmacists in fulfilling all the opportunities they have when counselling pregnant women.",
publisher = "Bentham Science Publ Ltd, Sharjah",
journal = "Current Pharmaceutical Design",
title = "Women's Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists",
volume = "25",
number = "5",
pages = "469-482",
doi = "10.2174/1381612825666190321110420"
}

Ceulemans, M., Lupattelli, A., Nordeng, H., Odalović, M., Twigg, M. J.,& Foulon, V.. (2019). Women's Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists. in Current Pharmaceutical Design
Bentham Science Publ Ltd, Sharjah., 25(5), 469-482.
https://doi.org/10.2174/1381612825666190321110420

Ceulemans M, Lupattelli A, Nordeng H, Odalović M, Twigg MJ, Foulon V. Women's Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists. in Current Pharmaceutical Design. 2019;25(5):469-482.
doi:10.2174/1381612825666190321110420 .

Ceulemans, Michael, Lupattelli, Angela, Nordeng, Hedvig, Odalović, Marina, Twigg, Michael J., Foulon, Veerle, "Women's Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists" in Current Pharmaceutical Design, 25, no. 5 (2019):469-482,
https://doi.org/10.2174/1381612825666190321110420 . .

TY  - JOUR
AU  - Costa, Filipa Alves
AU  - Scullin, Claire
AU  - Al-Taani, Ghaith
AU  - Hawwa, Ahmed F
AU  - Anderson, Claire
AU  - Bezverhni, Zinaida
AU  - Binakaj, Zahida
AU  - Cordina, Maria
AU  - Foulon, Veerle
AU  - Garcia de Bikuña, Borja
AU  - de Gier, Han
AU  - Gerd Granås, Anne
AU  - Grinstova, Olga
AU  - Griese-Mammen, Nina
AU  - Grincevicius, Jonas
AU  - Grinceviciene, Svitrigaile
AU  - Kaae, Susanne
AU  - Kubiliene, Loreta
AU  - Mariño, Eduardo L
AU  - Martins, Silvia
AU  - Modamio, Pilar
AU  - Nadin, Giancarlo
AU  - Stig Nørgaard, Lotte
AU  - Obarcanin, Emina
AU  - Tadić, Ivana
AU  - Tasić, Ljiljana
AU  - McElnay, James C
AU  - Hersberger, Kurt E
AU  - Westerlund, Tommy
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4211
AB  - Rationale, aims, and objectives: Pharmaceutical care involves patient-centred pharmacist activity to improve medicines management by patients. The implementation of this service in a comprehensive manner, however, requires considerable organisation and effort, and indeed, it is often not fully implemented in care settings. The main objective was to assess how pharmaceutical care provision within community pharmacy has evolved over time in Europe.

Method: A cross-sectional questionnaire-based survey of community pharmacies, using a modified version of the Behavioural Pharmaceutical Care Scale (BPCS) was conducted in late 2012/early 2013 within 16 European countries and compared with an earlier assessment conducted in 2006.

Results: The provision of comprehensive pharmaceutical care has slightly improved in all European countries that participated in both editions of this survey (n = 8) with progress being made particularly in Denmark and Switzerland. Moreover, there was a wider country uptake, indicating spread of the concept. However, due to a number of limitations, the results should be interpreted with caution. Using combined data from participating countries, the provision of pharmaceutical care was positively correlated with the participation of the community pharmacists in patient-centred activities, routine use of pharmacy software with access to clinical data, participation in multidisciplinary team meetings, and having specialized education.

Conclusions: The present study demonstrated a slight evolution in self-reported provision of pharmaceutical care by community pharmacists across Europe, as measured by the BPCS. The slow progress suggests a range of barriers, which are preventing pharmacists moving beyond traditional roles. Support from professional bodies and more patient-centred community pharmacy contracts, including remuneration for pharmaceutical care services, are likely to be required if quicker progress is to be made in the future.
PB  - Wiley
T2  - Journal of evaluation in clinical practice
T1  - Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?
VL  - 23
IS  - 6
SP  - 1336
EP  - 1347
DO  - 10.1111/jep.12783
ER  - 

@article{
author = "Costa, Filipa Alves and Scullin, Claire and Al-Taani, Ghaith and Hawwa, Ahmed F and Anderson, Claire and Bezverhni, Zinaida and Binakaj, Zahida and Cordina, Maria and Foulon, Veerle and Garcia de Bikuña, Borja and de Gier, Han and Gerd Granås, Anne and Grinstova, Olga and Griese-Mammen, Nina and Grincevicius, Jonas and Grinceviciene, Svitrigaile and Kaae, Susanne and Kubiliene, Loreta and Mariño, Eduardo L and Martins, Silvia and Modamio, Pilar and Nadin, Giancarlo and Stig Nørgaard, Lotte and Obarcanin, Emina and Tadić, Ivana and Tasić, Ljiljana and McElnay, James C and Hersberger, Kurt E and Westerlund, Tommy",
year = "2017",
abstract = "Rationale, aims, and objectives: Pharmaceutical care involves patient-centred pharmacist activity to improve medicines management by patients. The implementation of this service in a comprehensive manner, however, requires considerable organisation and effort, and indeed, it is often not fully implemented in care settings. The main objective was to assess how pharmaceutical care provision within community pharmacy has evolved over time in Europe.

Method: A cross-sectional questionnaire-based survey of community pharmacies, using a modified version of the Behavioural Pharmaceutical Care Scale (BPCS) was conducted in late 2012/early 2013 within 16 European countries and compared with an earlier assessment conducted in 2006.

Results: The provision of comprehensive pharmaceutical care has slightly improved in all European countries that participated in both editions of this survey (n = 8) with progress being made particularly in Denmark and Switzerland. Moreover, there was a wider country uptake, indicating spread of the concept. However, due to a number of limitations, the results should be interpreted with caution. Using combined data from participating countries, the provision of pharmaceutical care was positively correlated with the participation of the community pharmacists in patient-centred activities, routine use of pharmacy software with access to clinical data, participation in multidisciplinary team meetings, and having specialized education.

Conclusions: The present study demonstrated a slight evolution in self-reported provision of pharmaceutical care by community pharmacists across Europe, as measured by the BPCS. The slow progress suggests a range of barriers, which are preventing pharmacists moving beyond traditional roles. Support from professional bodies and more patient-centred community pharmacy contracts, including remuneration for pharmaceutical care services, are likely to be required if quicker progress is to be made in the future.",
publisher = "Wiley",
journal = "Journal of evaluation in clinical practice",
title = "Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?",
volume = "23",
number = "6",
pages = "1336-1347",
doi = "10.1111/jep.12783"
}

Costa, F. A., Scullin, C., Al-Taani, G., Hawwa, A. F., Anderson, C., Bezverhni, Z., Binakaj, Z., Cordina, M., Foulon, V., Garcia de Bikuña, B., de Gier, H., Gerd Granås, A., Grinstova, O., Griese-Mammen, N., Grincevicius, J., Grinceviciene, S., Kaae, S., Kubiliene, L., Mariño, E. L., Martins, S., Modamio, P., Nadin, G., Stig Nørgaard, L., Obarcanin, E., Tadić, I., Tasić, L., McElnay, J. C., Hersberger, K. E.,& Westerlund, T.. (2017). Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?. in Journal of evaluation in clinical practice
Wiley., 23(6), 1336-1347.
https://doi.org/10.1111/jep.12783

Costa FA, Scullin C, Al-Taani G, Hawwa AF, Anderson C, Bezverhni Z, Binakaj Z, Cordina M, Foulon V, Garcia de Bikuña B, de Gier H, Gerd Granås A, Grinstova O, Griese-Mammen N, Grincevicius J, Grinceviciene S, Kaae S, Kubiliene L, Mariño EL, Martins S, Modamio P, Nadin G, Stig Nørgaard L, Obarcanin E, Tadić I, Tasić L, McElnay JC, Hersberger KE, Westerlund T. Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?. in Journal of evaluation in clinical practice. 2017;23(6):1336-1347.
doi:10.1111/jep.12783 .

Costa, Filipa Alves, Scullin, Claire, Al-Taani, Ghaith, Hawwa, Ahmed F, Anderson, Claire, Bezverhni, Zinaida, Binakaj, Zahida, Cordina, Maria, Foulon, Veerle, Garcia de Bikuña, Borja, de Gier, Han, Gerd Granås, Anne, Grinstova, Olga, Griese-Mammen, Nina, Grincevicius, Jonas, Grinceviciene, Svitrigaile, Kaae, Susanne, Kubiliene, Loreta, Mariño, Eduardo L, Martins, Silvia, Modamio, Pilar, Nadin, Giancarlo, Stig Nørgaard, Lotte, Obarcanin, Emina, Tadić, Ivana, Tasić, Ljiljana, McElnay, James C, Hersberger, Kurt E, Westerlund, Tommy, "Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?" in Journal of evaluation in clinical practice, 23, no. 6 (2017):1336-1347,
https://doi.org/10.1111/jep.12783 . .

TY  - JOUR
AU  - Costa, Filipa A.
AU  - Scullin, Claire
AU  - Al-Taani, Ghaith
AU  - Hawwa, Ahmed F.
AU  - Anderson, Claire
AU  - Bezverhni, Zinaida
AU  - Binakaj, Zahida
AU  - Cordina, Maria
AU  - Foulon, Veerle
AU  - Garcia de Bikuna, Borja
AU  - de Gier, Han
AU  - Granas, Anne Gerd
AU  - Grinstova, Olga
AU  - Griese-Mammen, Nina
AU  - Grincevicius, Jonas
AU  - Grinceviciene, Svitrigaile
AU  - Kaae, Susanne
AU  - Kubiliene, Loreta
AU  - Marino, Eduardo L.
AU  - Martins, Silvia
AU  - Modamio, Pilar
AU  - Nadin, Giancarlo
AU  - Norgaard, Lotte Stig
AU  - Obarcanin, Emina
AU  - Tadić, Ivana
AU  - Tasić, Ljiljana
AU  - McElnay, James C.
AU  - Hersberger, Kurt E.
AU  - Westerlund, Tommy
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2846
AB  - Rationale, Aims, and ObjectivesPharmaceutical care involves patient-centred pharmacist activity to improve medicines management by patients. The implementation of this service in a comprehensive manner, however, requires considerable organisation and effort, and indeed, it is often not fully implemented in care settings. The main objective was to assess how pharmaceutical care provision within community pharmacy has evolved over time in Europe. MethodA cross-sectional questionnaire-based survey of community pharmacies, using a modified version of the Behavioural Pharmaceutical Care Scale (BPCS) was conducted in late 2012/early 2013 within 16 European countries and compared with an earlier assessment conducted in 2006. ResultsThe provision of comprehensive pharmaceutical care has slightly improved in all European countries that participated in both editions of this survey (n=8) with progress being made particularly in Denmark and Switzerland. Moreover, there was a wider country uptake, indicating spread of the concept. However, due to a number of limitations, the results should be interpreted with caution. Using combined data from participating countries, the provision of pharmaceutical care was positively correlated with the participation of the community pharmacists in patient-centred activities, routine use of pharmacy software with access to clinical data, participation in multidisciplinary team meetings, and having specialized education. ConclusionsThe present study demonstrated a slight evolution in self-reported provision of pharmaceutical care by community pharmacists across Europe, as measured by the BPCS. The slow progress suggests a range of barriers, which are preventing pharmacists moving beyond traditional roles. Support from professional bodies and more patient-centred community pharmacy contracts, including remuneration for pharmaceutical care services, are likely to be required if quicker progress is to be made in the future.
PB  - Wiley, Hoboken
T2  - Journal of Evaluation in Clinical Practice
T1  - Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?
VL  - 23
IS  - 6
SP  - 1336
EP  - 1347
DO  - 10.1111/jep.12783
ER  - 

@article{
author = "Costa, Filipa A. and Scullin, Claire and Al-Taani, Ghaith and Hawwa, Ahmed F. and Anderson, Claire and Bezverhni, Zinaida and Binakaj, Zahida and Cordina, Maria and Foulon, Veerle and Garcia de Bikuna, Borja and de Gier, Han and Granas, Anne Gerd and Grinstova, Olga and Griese-Mammen, Nina and Grincevicius, Jonas and Grinceviciene, Svitrigaile and Kaae, Susanne and Kubiliene, Loreta and Marino, Eduardo L. and Martins, Silvia and Modamio, Pilar and Nadin, Giancarlo and Norgaard, Lotte Stig and Obarcanin, Emina and Tadić, Ivana and Tasić, Ljiljana and McElnay, James C. and Hersberger, Kurt E. and Westerlund, Tommy",
year = "2017",
abstract = "Rationale, Aims, and ObjectivesPharmaceutical care involves patient-centred pharmacist activity to improve medicines management by patients. The implementation of this service in a comprehensive manner, however, requires considerable organisation and effort, and indeed, it is often not fully implemented in care settings. The main objective was to assess how pharmaceutical care provision within community pharmacy has evolved over time in Europe. MethodA cross-sectional questionnaire-based survey of community pharmacies, using a modified version of the Behavioural Pharmaceutical Care Scale (BPCS) was conducted in late 2012/early 2013 within 16 European countries and compared with an earlier assessment conducted in 2006. ResultsThe provision of comprehensive pharmaceutical care has slightly improved in all European countries that participated in both editions of this survey (n=8) with progress being made particularly in Denmark and Switzerland. Moreover, there was a wider country uptake, indicating spread of the concept. However, due to a number of limitations, the results should be interpreted with caution. Using combined data from participating countries, the provision of pharmaceutical care was positively correlated with the participation of the community pharmacists in patient-centred activities, routine use of pharmacy software with access to clinical data, participation in multidisciplinary team meetings, and having specialized education. ConclusionsThe present study demonstrated a slight evolution in self-reported provision of pharmaceutical care by community pharmacists across Europe, as measured by the BPCS. The slow progress suggests a range of barriers, which are preventing pharmacists moving beyond traditional roles. Support from professional bodies and more patient-centred community pharmacy contracts, including remuneration for pharmaceutical care services, are likely to be required if quicker progress is to be made in the future.",
publisher = "Wiley, Hoboken",
journal = "Journal of Evaluation in Clinical Practice",
title = "Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?",
volume = "23",
number = "6",
pages = "1336-1347",
doi = "10.1111/jep.12783"
}

Costa, F. A., Scullin, C., Al-Taani, G., Hawwa, A. F., Anderson, C., Bezverhni, Z., Binakaj, Z., Cordina, M., Foulon, V., Garcia de Bikuna, B., de Gier, H., Granas, A. G., Grinstova, O., Griese-Mammen, N., Grincevicius, J., Grinceviciene, S., Kaae, S., Kubiliene, L., Marino, E. L., Martins, S., Modamio, P., Nadin, G., Norgaard, L. S., Obarcanin, E., Tadić, I., Tasić, L., McElnay, J. C., Hersberger, K. E.,& Westerlund, T.. (2017). Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?. in Journal of Evaluation in Clinical Practice
Wiley, Hoboken., 23(6), 1336-1347.
https://doi.org/10.1111/jep.12783

Costa FA, Scullin C, Al-Taani G, Hawwa AF, Anderson C, Bezverhni Z, Binakaj Z, Cordina M, Foulon V, Garcia de Bikuna B, de Gier H, Granas AG, Grinstova O, Griese-Mammen N, Grincevicius J, Grinceviciene S, Kaae S, Kubiliene L, Marino EL, Martins S, Modamio P, Nadin G, Norgaard LS, Obarcanin E, Tadić I, Tasić L, McElnay JC, Hersberger KE, Westerlund T. Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?. in Journal of Evaluation in Clinical Practice. 2017;23(6):1336-1347.
doi:10.1111/jep.12783 .

Costa, Filipa A., Scullin, Claire, Al-Taani, Ghaith, Hawwa, Ahmed F., Anderson, Claire, Bezverhni, Zinaida, Binakaj, Zahida, Cordina, Maria, Foulon, Veerle, Garcia de Bikuna, Borja, de Gier, Han, Granas, Anne Gerd, Grinstova, Olga, Griese-Mammen, Nina, Grincevicius, Jonas, Grinceviciene, Svitrigaile, Kaae, Susanne, Kubiliene, Loreta, Marino, Eduardo L., Martins, Silvia, Modamio, Pilar, Nadin, Giancarlo, Norgaard, Lotte Stig, Obarcanin, Emina, Tadić, Ivana, Tasić, Ljiljana, McElnay, James C., Hersberger, Kurt E., Westerlund, Tommy, "Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?" in Journal of Evaluation in Clinical Practice, 23, no. 6 (2017):1336-1347,
https://doi.org/10.1111/jep.12783 . .